Compound Detail
CHEMBL2443262
OLICERIDINE 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL2443262 |
| Name | OLICERIDINE |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | DMNOVGJWPASQDL-OAQYLSRUSA-N |
| Therapeutic | ✓ Yes |
11
Targets
29
Activities
3
Assay Types
14
PK Parameters
20
Publications
6
Known Names
2
Indications
1
Mechanisms
Molecular Properties
386.6
MW (Da)
4.69
ALogP
5
HBA
1
HBD
43.4
PSA (Ų)
0.70
QED
0
Ro5 Violations
7
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 2020 |
| Availability | Prescription |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Mu opioid receptor agonist | AGONIST | Mu-type opioid receptor | ✓ | ✓ |
Indications
Acute Pain Pain
ATC Classification
N02AX07
oliceridine
Level 1: NERVOUS SYSTEM
Level 2: ANALGESICS
Drug Warnings
Black Box Warning
respiratory toxicity
Black Box Warning
misuse
Activity Summary
EC50 15 meas. best 8.74
IC50 8 meas. best 5.34
Ki 6 meas. best 8.84
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Mu-type opioid receptor CHEMBL233 | Ki | 8.84 | 8.2475 | 1.5 | 4 |
| Mu-type opioid receptor CHEMBL233 | EC50 | 8.74 | 8.1214 | 1.8 | 7 |
| Mu-type opioid receptor CHEMBL2858 | EC50 | 8.62 | 7.78 | 2.4 | 6 |
| Kappa-type opioid receptor CHEMBL237 | EC50 | 5.85 | 5.85 | 1400.0 | 1 |
| Delta-type opioid receptor CHEMBL236 | EC50 | 5.55 | 5.55 | 2800.0 | 1 |
| Cytochrome P450 2D6 CHEMBL289 | IC50 | 5.34 | 5.34 | 4600.0 | 1 |
| Sodium channel protein type 5 subunit alpha CHEMBL1980 | IC50 | 5.33 | 5.055 | 4700.0 | 2 |
| Voltage-gated inwardly rectifying potassium channel KCNH2 CHEMBL240 | IC50 | 5.26 | 5.2433 | 5500.0 | 3 |
| D(3) dopamine receptor CHEMBL234 | Ki | 5.16 | 5.16 | 6860.0 | 1 |
| Cytochrome P450 3A4 CHEMBL340 | IC50 | 4.87 | 4.87 | 13600.0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1C CHEMBL1940 | IC50 | 4.44 | 4.44 | 36000.0 | 1 |
| D(2) dopamine receptor CHEMBL217 | Ki | 4.08 | 4.08 | 83200.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 145.46 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 145.86 | ng.hr.mL-1 | Rattus norvegicus |
| CL | 1114.0 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 313.6 | mL.min-1.kg-1 | Homo sapiens |
| CL | 465.0 | mL.min-1.kg-1 | Canis lupus familiaris |
| CL | 58.32 | mL.min-1.kg-1 | Rattus norvegicus |
| Cmax | 643.11 | nM | Rattus norvegicus |
| Fu | 0.22 | - | Homo sapiens |
| Fu | 0.36 | - | Rattus norvegicus |
| Fu | 0.023 | - | Canis lupus familiaris |
| MRT | 0.82 | hr | Rattus norvegicus |
| T1/2 | 1.21 | hr | Rattus norvegicus |
| T1/2 | 0.1086 | hr | - |
| Vd | 6.392 | L.kg-1 | Rattus norvegicus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine